In Depth

Psoriasis biosimilars and pricing changes herald treatment paradigm disruptions

What is the pharmacy of the future?

Obesity trial surge puts the focus back on decentralisation

A slow start for self- amplifying mRNA vaccines

For pharma companies, the possibilities of green chemistry are huge

Will the tide turn for the wave of pharma layoffs?